Log In
Print
BCIQ
Print
Print this Print this
 

TMG-123

  Manage Alerts
Collapse Summary General Information
Company Teijin Pharma Ltd.
DescriptionGlucokinase (GCK; GK) activator
Molecular Target Glucokinase (GCK) (GK)
Mechanism of ActionGlucokinase activator
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today